Mohd Nor Norazmi

2.2k total citations
134 papers, 1.6k citations indexed

About

Mohd Nor Norazmi is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Mohd Nor Norazmi has authored 134 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 51 papers in Molecular Biology and 43 papers in Immunology. Recurrent topics in Mohd Nor Norazmi's work include Tuberculosis Research and Epidemiology (47 papers), Mycobacterium research and diagnosis (28 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Mohd Nor Norazmi is often cited by papers focused on Tuberculosis Research and Epidemiology (47 papers), Mycobacterium research and diagnosis (28 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Mohd Nor Norazmi collaborates with scholars based in Malaysia, Cuba and Australia. Mohd Nor Norazmi's co-authors include Nik Soriani Yaacob, Armando Acosta, María E. Sarmiento, Md. Murad Hossain, Nadine Álvarez, Zafarina Zainuddin, Asma Abdullah Nurul, Hisham Atan Edinur, Alina Puig and Thirumulu Ponnuraj Kannan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mohd Nor Norazmi

129 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohd Nor Norazmi Malaysia 21 516 444 421 364 198 134 1.6k
Mohammad Azhar Kamal Saudi Arabia 22 394 0.8× 586 1.3× 223 0.5× 253 0.7× 47 0.2× 65 1.8k
Bryan C. Mounce United States 20 420 0.8× 488 1.1× 232 0.6× 265 0.7× 95 0.5× 42 1.3k
Nicolás Villegas‐Sepúlveda Mexico 26 550 1.1× 785 1.8× 189 0.4× 293 0.8× 51 0.3× 71 1.9k
Shaikh M. Atif United States 18 722 1.4× 774 1.7× 842 2.0× 181 0.5× 81 0.4× 41 2.3k
Hongyan Chen China 31 409 0.8× 1.6k 3.7× 432 1.0× 235 0.6× 305 1.5× 121 3.1k
Masayuki Sudoh Japan 24 327 0.6× 991 2.2× 201 0.5× 773 2.1× 42 0.2× 53 2.0k
Leen Delang Belgium 31 1.4k 2.7× 602 1.4× 215 0.5× 544 1.5× 217 1.1× 97 2.7k
Kazuya I.P.J. Hidari Japan 28 307 0.6× 1.2k 2.7× 508 1.2× 646 1.8× 56 0.3× 75 2.4k
N. Venkatesh Prajna India 39 597 1.2× 492 1.1× 256 0.6× 375 1.0× 26 0.1× 181 4.3k
Yannick Poquet France 25 1.1k 2.2× 918 2.1× 1.6k 3.8× 856 2.4× 155 0.8× 35 3.4k

Countries citing papers authored by Mohd Nor Norazmi

Since Specialization
Citations

This map shows the geographic impact of Mohd Nor Norazmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohd Nor Norazmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohd Nor Norazmi more than expected).

Fields of papers citing papers by Mohd Nor Norazmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohd Nor Norazmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohd Nor Norazmi. The network helps show where Mohd Nor Norazmi may publish in the future.

Co-authorship network of co-authors of Mohd Nor Norazmi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohd Nor Norazmi. A scholar is included among the top collaborators of Mohd Nor Norazmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohd Nor Norazmi. Mohd Nor Norazmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norazmi, Mohd Nor, et al.. (2024). Live Attenuated Bacterial Vectors as Vehicles for DNA Vaccine Delivery: A Mini Review. Malaysian Journal of Medical Sciences. 31(6). 6–20.
2.
Dhaliwal, Satvinder S., et al.. (2023). Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia. International Journal of Environmental Research and Public Health. 20(2). 1647–1647. 7 indexed citations
3.
Norazmi, Mohd Nor, et al.. (2023). DNA Profiling in Human Identification: From Past to Present. Malaysian Journal of Medical Sciences. 30(6). 5–21. 3 indexed citations
4.
Chuah, Candy, et al.. (2022). Mass spectrometry-based immunopeptidomics and computational vaccinology strategies for the identification of universal Shigella immunogenic candidates. Computers in Biology and Medicine. 148. 105900–105900. 2 indexed citations
5.
Norazmi, Mohd Nor, et al.. (2022). Immunometabolism of Immune Cells in Mucosal Environment Drives Effector Responses against Mycobacterium tuberculosis. International Journal of Molecular Sciences. 23(15). 8531–8531. 9 indexed citations
6.
Leow, Chiuan Yee, Candy Chuah, Abu Bakar Abdul Majeed, Mohd Nor Norazmi, & Chiuan Herng Leow. (2021). Application of Reverse Vaccinology and Immunoinformatic Strategies for the Identification of Vaccine Candidates Against Shigella flexneri. Methods in molecular biology. 2414. 17–35. 3 indexed citations
7.
Norazmi, Mohd Nor, et al.. (2019). Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC). Molecular Immunology. 117. 54–64. 6 indexed citations
9.
Sarmiento, María E., et al.. (2017). Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis. Journal of Immunology Research. 2017. 1–10. 26 indexed citations
10.
Sarmiento, María E., Fátima Reyes, Louise U. Kim, et al.. (2016). Selection of phage-displayed human antibody fragments specific for CD1b presenting the Mycobacterium tuberculosis glycolipid Ac2SGL. International Journal of Mycobacteriology. 5(2). 120–127. 4 indexed citations
11.
Yaacob, Nik Soriani, et al.. (2016). Cell Cycle Modulation of MCF-7 and MDA-MB-231 by a Sub-Fraction of Strobilanthes crispus and its Combination with Tamoxifen. Asian Pacific Journal of Cancer Prevention. 16(18). 8135–8140. 20 indexed citations
12.
Norazmi, Mohd Nor, et al.. (2015). Halal pharmaceutical industry: opportunities and challenges. Trends in Pharmacological Sciences. 36(8). 496–497. 30 indexed citations
13.
Acosta, Armando, et al.. (2015). Sequence comparison of six human microRNAs genes between tuberculosis patients and healthy individuals. International Journal of Mycobacteriology. 4(4). 341–346. 9 indexed citations
14.
Mohamud, Rohimah, Daniel Yero, Nadine Álvarez, et al.. (2013). Immunogenicity of recombinant Mycobacterium bovis bacille Calmette–Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens. BMC Immunology. 14(S1). S5–S5. 15 indexed citations
15.
Acevedo, Reinaldo, Armando Acosta, Hervé Bercovier, et al.. (2013). Second international congress on immunopharmacology: delivery systems and current strategies for drug design. BMC Immunology. 14(S1). S1–S1. 1 indexed citations
16.
Fernández-Castillo, Sonsire, José L. Pérez, Fátima Reyes, et al.. (2010). Evaluation of the potential of Mycobacterium smegmatis as vaccine Candidate against tuberculosis by in silico and in vivo studies. SHILAP Revista de lepidopterología. 9 indexed citations
17.
Álvarez, Nadine, et al.. (2010). Purificación de inmunoglobulina A secretora a partir de calostro humano. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Acosta, Armando, Mohd Nor Norazmi, & María E. Sarmiento. (2010). Antibody mediated immunity - a missed opportunity in the fight against tuberculosis?. PubMed. 17(2). 66–7. 11 indexed citations
20.
Norazmi, Mohd Nor, A Hohmann, John M. Skinner, & John Bradley. (1989). Expression of MHC class I and class II antigens in colonic carcinomas. Pathology. 21(4). 248–253. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026